CA Patent

CA2819234A1 — Pharmaceutical compositions of iron for oral administration

Assigned to Merrion Research Ill Ltd · Expires 2012-07-12 · 14y expired

What this patent protects

The present invention generally relates to orally administered pharmaceutical compositions of iron compounds with medium chain fatty acid salts. The invention further relates to methods of using the pharmaceutical compositions to treat iron deficiency and related disorders.

USPTO Abstract

The present invention generally relates to orally administered pharmaceutical compositions of iron compounds with medium chain fatty acid salts. The invention further relates to methods of using the pharmaceutical compositions to treat iron deficiency and related disorders.

Drugs covered by this patent

Patent Metadata

Patent number
CA2819234A1
Jurisdiction
CA
Classification
—
Expires
2012-07-12
Drug substance claim
No
Drug product claim
No
Assignee
Merrion Research Ill Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.